GSK announced that its new global headquarters will be in central London. The company will move to the new headquarters in 2024 from its current location in Brentford, West London. The site, which is under construction and scheduled for completion next year, was selected by the company following a comprehensive search of potential new HQ sites across London. Emma Walmsley, CEO, GSK said: "Our new headquarters represents an important next step for GSK. As a global biopharma company, we are proud to call London our home and look forward to the opportunities for even closer collaboration with the city’s world-class science, academic and healthcare institutions."
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on GSK:
- GSK announces new 48-week data from MOMENTUM Phase 3 trial
- GSK upgraded to Buy from Add at AlphaValue/Baader
- GSK says PERLA ph. 2 trial achieved ‘very promising results’ on primary endpoint
- GSK says court has dismissed all cases alleging five remaining cancers in MDL
- Florida district court grants Sanofi, GSK summary judgment of Zantac suits
